Trials / Unknown
UnknownNCT05116410
A Study of HS-20094 in Healthy Participants
A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-20094
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study includes two parts (Single Ascending Dose, SAD; Multiple-Ascending Dose, MAD) and enrolls healthy participants. Participants in SAD accept single subcutaneous (SC) injection of HS-20094 and participants in MAD accept SC injection of HS-20094 once weekly for 4 weeks. The main purpose of this study is to determine 1) The safety of HS-20094; 2) How much HS-20094 gets into the bloodstream and how long it takes the body to get rid of it.3) How HS-20094 affects the levels of blood sugar, insulin and weight.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HS-20094 | Administrated SC |
| DRUG | Placebo | Administrated SC |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-10-31
- Completion
- 2022-12-31
- First posted
- 2021-11-11
- Last updated
- 2022-07-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05116410. Inclusion in this directory is not an endorsement.